# Assessment and Prediction of Cetuximab-Induced Hypersensitivity Reactions Using Cetuximab Specific IgE Detection

> **NCT03485638** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 400 (estimated)

## Conditions studied

- Tumor Disease Including Colorectal Cancer
- Head & Neck Squamous Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03485638
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11-04
- **Primary completion:** 2020-11-03
- **Final completion:** 2020-11-03
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03485638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03485638, "Assessment and Prediction of Cetuximab-Induced Hypersensitivity Reactions Using Cetuximab Specific IgE Detection". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03485638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*